Buspirone and Melatonin for Depression Following Traumatic Brain Injury

Clinical trial NCT04400266 · RECRUITING

Trial details

NCT number: NCT04400266
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Depression Brain Injuries, Traumatic

Start date: 2020-08-01
Primary completion: 2028-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.